BioCentury
ARTICLE | Management Tracks

Cassidy joins SpringWorks as CMO

Plus: Centogene, Lava, Umoja and SynOx

July 28, 2021 12:35 AM UTC

James “Jim” Cassidy will become CMO at rare disease and cancer company SpringWorks Therapeutics Inc. (NASDAQ:SWTX), succeeding Jens Renstrup, who is leaving the company. Cassidy was VP of oncology strategic program direction at Regeneron Pharmaceuticals Inc. (NASDAQ:REGN).

Centogene N.V. (NASDAQ:CNTG) hired Patrice Denèfle as CSO, effective Aug. 16. Denèfle, who succeeds Phil Lambert, was most recently CSO at 4P-Pharma, before which he was general manager of the Roche (SIX:ROG; OTCQX:RHHBY) Institute for Research and Translational Medicine...